JPRN-jRCT2080221293
Unknown
Phase 3
An open-label, add-on, drug-drug interaction study to assess the effect of FYX-051 on the pharmacokinetics and safety of warfarin in Japanese healthy adult male
ConditionsHealthy adult male
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Healthy adult male
- Sponsor
- SANWA KAGAKU KENKYUSHO CO.,LTD.
- Enrollment
- 12
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Japanese healthy adult male
Exclusion Criteria
- •Patients with any disease
- •Subjects with any history of diseases that might affect the assessment in the study
- •Subjects expressing the CYP2C9\*3 genotype
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Famotidine with or without Tenofovir on the Pharmacokinetics of Atazanavir when given with Ritonavir in HIV-Infected Subjects. Revised Protocol 02 incorporating amendment 03 (Version 1.0, Date 09-Mar-2007) and amendment 04 (Version 1.0, Date 02-Jul-2007). And Pharmacogenetics Blood Sample Amendment 01 - Site Specific (Version 5.0, Date 14-Sep-2006).HIV infected SubjectsMedDRA version: 8.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2006-003163-31-GBBristol-Myers Squibb International Corporation36
Completed
Not Applicable
A Phase I, open-label, drug-drug interaction study between multiple oral doses of GLPG1972 and a single dose of midazolam in healthy male subjects.NL-OMON44611Galapagos NV18
Active, not recruiting
Phase 1
A study in healthy volunteers to discover how the test medicine interacts with other approved medicines1. Non-alcoholic steatohepatitis (NASH)2. Antipsychotic-induced weight gain (AIWG)Not ApplicableISRCTN10379288Corcept Therapeutics (United States)30
Completed
Not Applicable
An Open-Label Two-Way Drug-Drug Interaction Study to Assess the Effect of Tenofovir on the Pharmacokinetics of BMS-790052 and the Effect of BMS-790052 on the Pharmacokinetics of Tenofovir in Healthy SubjectsHepatitis Cviral liver inflammation10047438NL-OMON36725Bristol-Myers Squibb21
Active, not recruiting
Phase 1
An Open-label Drug-Drug Interaction Study to Assess the Effects ofNemolizumab on Cytochrome P450 Substrates in Subjects with Moderate-to-Serve Atopic DermatitisModerate-to-severe atopic dermatitisMedDRA version: 21.1Level: LLTClassification code 10003639Term: Atopic dermatitisSystem Organ Class: 100000004858Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2020-000229-24-BGGalderma S.A.25